Received May 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| SMALLMNK | SMALLPOX + MONKEYPOX (JYNNEOS) | BAVARIAN NORDIC | 2 | FDP00015 | IM / LA |
The treatment was the second series of a two-series vaccination; the outcome was uneventful, with no symptoms or signs of reaction reported.
HIV infection, asymptomatic Moderate anal dysplasia, histologically confirmed Allergic rhinitis Pure hypercholesterolemia BMI 28.0-28.9, adult Need for HPV vaccination Vitamin D insufficiency COVID-19 vaccination declined
HIV infection, asymptomatic
psyllium husk (METAMUCIL) 0.4 gram capsule ergocalciferol (VITAMIN D2) 1,250 mcg (50,000 unit) cap bictegrav-emtricit-tenofov (BIKTARVY) 50-200-25 mg tab rosuvastatin (CRESTOR) 10 mg tab prochlorperazine (COMPAZINE) 5 mg tab vitamin C with
NKDA
N/A